文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

氯胺酮与依托咪酯及围插管期低血压:一项全国急诊气道登记研究

Ketamine Versus Etomidate and Peri-intubation Hypotension: A National Emergency Airway Registry Study.
PubMed 文献 · Acad Emerg Med · 2020-07-18
一句话结论在急诊插管中,使用氯胺酮者围插管期低血压风险高于依托咪酯(aOR=1.4),作者认为不应仅因血流动力学担忧而优先选择氯胺酮。

该研究分析2016至2018年间25个急诊科收治的>14岁急诊插管患者数据,排除插管前低血压(收缩压<100 mmHg)或插管前心跳骤停者,比较氯胺酮与依托咪酯诱导后围插管期低血压的发生风险。结果氯胺酮组围插管期低血压发生率为18.3%,依托咪酯组为12.4%(差值5.9%,95%CI 2.9%~8.8%);氯胺酮组接受低血压治疗的比例也更高(差值6.5%,95%CI 3.9%~9.3%)。多因素回归校正后,氯胺酮仍与更高的围插管期低血压风险相关(aOR=1.4,95%CI 1.2~1.7)及更高的低血压治疗风险相关(aOR=1.8,95%CI 1.4~2.0)。作者结论提示,在获得更多数据前,临床医生不应仅因担心血流动力学不稳定而优先选择氯胺酮而非依托咪酯。

要点

  • 在排除插管前低血压(收缩压<100 mmHg)或心跳骤停的急诊插管患者中,氯胺酮组围插管期低血压发生率为18.3%,依托咪酯组为12.4%(差值5.9%,95%CI 2.9%~8.8%)。
  • 校正患者人口学、困难气道特征和插管方式后,氯胺酮组围插管期低血压风险仍高于依托咪酯组(aOR=1.4,95%CI 1.2~1.7)。
  • 氯胺酮组接受低血压治疗(如静脉输液或血管升压药)的比例更高(差值6.5%,95%CI 3.9%~9.3%;aOR=1.8,95%CI 1.4~2.0)。
  • 氯胺酮剂量≤1.0 mg/kg与>1.0 mg/kg之间、依托咪酯剂量≤0.3 mg/kg与>0.3 mg/kg之间,低血压的aOR均无差异。
  • 作者认为,基于血流动力学担忧,临床医生不应必然优先选择氯胺酮而非依托咪酯用于急诊插管患者。

适用人群与场景

  • 2016年至2018年间在25个急诊科进行的全国急诊气道登记中,年龄>14岁、接受急诊插管的患者。
  • 排除插管前低血压(收缩压<100 mmHg)或插管前心跳骤停的患者。

研究设计与关键结果

  • 研究类型为基于全国急诊气道登记的分析,纳入25个急诊科,年龄>14岁急诊插管患者,氯胺酮组738例,依托咪酯组6068例。
  • 氯胺酮组更常具有困难气道特征(效应量差值=8.8%,95%CI 5.3%~12.4%),更常使用视频喉镜插管(8.1%,95%CI 4.4%~12.0%)。
  • 主要终点围插管期低血压发生率:氯胺酮组18.3% vs 依托咪酯组12.4%,效应量差值=5.9%(95%CI 2.9%~8.8%)。
  • 次要终点接受低血压治疗的比例:氯胺酮组较依托咪酯组效应量差值=6.5%(95%CI 3.9%~9.3%)。
  • 多因素logistic回归校正人口学、困难气道特征和插管方式后,氯胺酮组围插管期低血压aOR=1.4(95%CI 1.2~1.7),接受低血压治疗aOR=1.8(95%CI 1.4~2.0)。
  • 氯胺酮剂量≤1.0 mg/kg与>1.0 mg/kg之间、依托咪酯剂量≤0.3 mg/kg与>0.3 mg/kg之间,低血压的aOR无差异。

证据类型、等级与局限

  • 证据类型:基于全国急诊气道登记的多中心分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于年龄>14岁、无插管前低血压(收缩压<100 mmHg)或心跳骤停的急诊插管患者,选择氯胺酮诱导时围插管期低血压风险高于依托咪酯(aOR=1.4,95%CI 1.2~1.7),需更警惕低血压并准备处理。
  • 作者认为,基于血流动力学担忧,临床医生不应必然优先选择氯胺酮而非依托咪酯用于急诊插管患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The hemodynamic impact of induction agents is a critically important consideration in emergency intubations. We assessed the relationship between peri-intubation hypotension and the use of ketamine versus etomidate as an induction agent for emergency department (ED) intubation.

METHODS: We analyzed ED intubation data for patients aged >14 years from the National Emergency Airway Registry performed in 25 EDs during 2016 through 2018. We excluded patients with preintubation hypotension (systolic blood pressure <100 mm Hg) or cardiac arrest prior to intubation. The primary outcome was peri-intubation hypotension. Secondary outcomes included interventions for hypotension (e.g., intravenous fluids or vasopressors). We report adjusted odds ratios (aOR) from multivariable logistic regression models controlling for patient demographics, difficult airway characteristics, and intubation modality.

RESULTS: There were 738 encounters with ketamine and 6,068 with etomidate. Patients receiving ketamine were more likely to have difficult airway characteristics (effect size difference = 8.8%, 95% confidence interval [CI] = 5.3% to 12.4%) and to undergo intubation with video laryngoscopy (8.1%, 95% CI = 4.4% to 12.0%). Peri-intubation hypotension incidence was 18.3% among patients receiving ketamine and 12.4% among patients receiving etomidate (effect size difference = 5.9%, 95% CI = 2.9% to 8.8%). Patients receiving ketamine were more likely to receive treatment for peri-intubation hypotension (effect size difference = 6.5%, 95% CI = 3.9% to 9.3%). In logistic regression analyses, patients receiving ketamine remained at higher risk for peri-intubation hypotension (aOR = 1.4, 95% CI = 1.2 to 1.7) and treatment for hypotension (aOR = 1.8, 95% CI = 1.4 to 2.0). There was no difference in the aOR of hypotension between patients receiving ketamine at doses ≤1.0 mg/kg versus >1.0 mg/kg or patients receiving etomidate at doses ≤0.3 mg/kg versus >0.3 mg/kg.

CONCLUSIONS: Pending additional data, our results suggest that clinicians should not necessarily prioritize ketamine over etomidate based on concern for hemodynamic compromise among ED patients undergoing intubation.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. April MD, Arana A, Schauer SG, et al. Ketamine Versus Etomidate and Peri-intubation Hypotension: A National Emergency Airway Registry Study. Acad Emerg Med. 2020. PMID: 32592205. doi:10.1111/acem.14063

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。